A novel mutation at ANTXR1 in an Indian patient with growth retardation–alopecia–pseudoanodontia–optic atrophy syndrome

• DOI: 10.1016/j.oooo.2017.07.009
• Publication Date: 2017-08-04T15:01:47Z
• Authors: Esita Chattopadhyay; Sandip Ghose; Anindita Ray; Nishat Anjum; Anjana Mazumdar; Bidyut Roy
• Keywords: Male; 0301 basic medicine; Microfilament Proteins; India; Alopecia; Receptors, Cell Surface; Neoplasm Proteins; 3. Good health; 03 medical and health sciences; Phenotype; Optic Atrophies, Hereditary; Mutation; Humans; Child; Growth Disorders; Anodontia

Growth retardation-alopecia-pseudoanodontia-optic atrophy (GAPO) syndrome (Online Mendelian Inheritance in Man [OMIM] ID 230740) is one of the rarest autosomal recessive syndromes. It is characterized by many phenotypes, including wide anterior fontanel, frontal bossing of the face, depressed nasal bridge, along with the 4 classic phenotypes contained in the name of the syndrome. Recent reports identified nonsense, missense, and splicing mutations at different exons of ANTXR1 responsible for GAPO syndrome in patients from different ethnic populations. Here, we are reporting a mutation at ANTXR1 in an Indian patient with GAPO syndrome.We describe an inherited mutation at ANTXR1 in a 6-year-old Indian boy with GAPO syndrome.Genomic DNA from the patient with the GAPO syndrome and his family members were screened for previously reported mutations at ANTXR1 by sequencing. Novel homozygous and heterozygous mutations in exon-3 of ANTXR1 (c.265 G > A, p.Gly89 Arg) were identified in the patient and in other members of the family, respectively. However, no mutated allele was identified in genomic DNA from unrelated healthy individuals. Bioinformatic analysis by different tools predicted the deleterious, damaging, or aberrant splicing effect of mutation on the protein.Functional inefficiency of ANTXR1 as a result of mutation might have led to GAPO syndrome.